| | HIV-resistant host factors | | Genetic | Genital mucosa |
| | KIR3D L1/S1 [59] | Protease inhibitors (SLPI, lactoferrin, serpins, cystatins, trappin-2/elafin) [2, 84–87] | | KIR2D L2/L3 [60] | | HLA class 1 alleles [61–65] |
Defensins () [2] | | IRF-1 [66] | CC- chemokines [9, 79, 80] | | TLR 9 [67] | APOBEC3G, TRIM5, tetherin, SAMHD1, LEDGF/p75 [81–83] | | CCR532 [68–76] | Elevated DC and NK cell frequencies/activities [58] | | CCR2b [77, 78] | CD4+- and CD8+-specific immune responses and reduced T-cell | | MIP-1 [79] | activation [2, 88–97] | MIP-1 [80]
| Cross-clade neutralizing specific IgA (transcytosis inhibition and ADCC activities) [2, 88–94, 98, 99] |
|
|